These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27467671)

  • 1. Serum Antibodies to Cytoskeletal Systems in Patients with Adult T-Cell Leukemia and Healthy HTLV-1 Carriers.
    Yasuda M; Nobunaga M
    Leuk Lymphoma; 1991; 4(5-6):375-80. PubMed ID: 27467671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibodies to cytoskeletal systems in patients with adult T-cell leukemia and infectious mononucleosis].
    Yasuda M; Nobunaga M
    Rinsho Ketsueki; 1989 Jul; 30(7):1005-9. PubMed ID: 2810784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to cytoskeletal systems in normal human serum.
    Yasuda M; Nobunaga M
    Fukuoka Igaku Zasshi; 1990 Oct; 81(10):323-30. PubMed ID: 1702082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin classes of antibody for human T-lymphotropic virus type-I (HTLV-I) in healthy donors and HTLV-I-associated disorders.
    Kamihira S; Sohda H; Oyakawa N; Moriuti Y; Momita S; Ikeda S; Yamada Y; Ichimaru M; Kinosita K; Okuda H
    Vox Sang; 1989; 56(3):168-73. PubMed ID: 2728394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Difference of antibody profile for human T-lymphotropic virus type-I (HTLV-I) among individuals].
    Kamihira S; Sohda H; Momita S; Amagasaki T; Yamada Y; Ikeda S; Tomonaga M; Ichimaru M; Kinosita K; Sawada T
    Rinsho Ketsueki; 1989 Jun; 30(6):823-9. PubMed ID: 2795893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.
    Ohtsubo H; Arima N; Tei C
    Leuk Lymphoma; 1999 May; 33(5-6):451-8. PubMed ID: 10342573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of anti-HTLV antibody titer, abnormal lymphocytes in HTLV carriers and HTLV genome negative adult T-cell leukemia-lymphoma.
    Shimoyama M; Seki S; Nagai M; Minato K; Kitamura T; Hoshino H; Miwa M; Tobinai K; Nagoshi H; Oosuga T
    Princess Takamatsu Symp; 1984; 15():71-6. PubMed ID: 6152761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Epstein-Barr virus infection in adult T-cell leukemia.
    Ueda S; Maeda Y; Yamaguchi T; Hanamoto H; Hijikata Y; Tanaka M; Takai S; Hirase C; Morita Y; Kanamaru A
    Hematology; 2008 Jun; 13(3):154-62. PubMed ID: 18702873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
    Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I
    Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
    Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
    Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
    Ahmadi Ghezeldasht S; Hedayati-Moghaddam MR; Habibi M; Mollahosseini F; Rafatpanah H; Miri R; Hatef Fard M; Sahebari M
    Int J Rheum Dis; 2018 Jan; 21(1):108-113. PubMed ID: 28261958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
    Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
    Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
    Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
    In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
    Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
    Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with adult T-cell leukemia.
    Uno H; Kawano K; Matsuoka H; Tsuda K
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):730-9. PubMed ID: 2618548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.